Simplex Trading
NAVB

Simplex Trading’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Simplex Trading’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,700
Closed -$1K – 10762
2022
Q4 		$1K Sell
5,700
-17,300
-75% -$4.33K ﹤0.01% 9044
2022
Q3 		$5K Buy
23,000
+3,200
+16% +$1.49K ﹤0.01% 8866
2022
Q2 		$14K Sell
19,800
-4,100
-17% -$3.48K ﹤0.01% 8010
2022
Q1 		$18K Sell
23,900
-8,200
-26% -$7.51K ﹤0.01% 8386
2021
Q4 		$32K Sell
32,100
-19,200
-37% -$27K ﹤0.01% 7840
2021
Q3 		$92K Hold
51,300
– – ﹤0.01% 6746
2021
Q2 		$93K Buy
51,300
+50,634
+7,603% +$89.5K ﹤0.01% 6850
2021
Q1 		$134K Buy
666
+543
+441% +$1.27K ﹤0.01% 5345
2020
Q4 		$26K Buy
123
+86
+232% +$203 ﹤0.01% 6809
2020
Q3 		$9K Buy
37
+23
+164% +$83 ﹤0.01% 6872
2020
Q2 		$5K Sell
14
-71
-84% -$136 ﹤0.01% 7027
2020
Q1 		$6K Buy
85
+14
+20% +$15 ﹤0.01% 6806
2019
Q4 		$8K Buy
71
+56
+373% +$48 ﹤0.01% 6530
2019
Q3 		$1K Buy
+15
New +$9 ﹤0.01% 7140
2015
Q4 		– Sell
-38
Closed -$101K – 6521
2015
Q3 		$101K Buy
+38
New +$1.43K 0.01% 1413
2015
Q1 		– Sell
-2
Closed -$3K – 5949
2014
Q4 		$3K Buy
+2
New +$55 ﹤0.01% 3593

Other funds holding NAVB

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

Simplex Trading's NAVB Position: Q2 2023 in Review

Simplex Trading sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2023, closing a stake of 28,416 shares — an estimated $4.53K sold.

Simplex Trading first reported a position in NAVB in Q4 2014 and held it in 17 quarters. The position peaked at $73K in Q2 2020. 23 funds tracked by Wall St. Rank hold NAVB as of Q2 2023.

  • Simplex Trading reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 28,416 Navidea Biopharmaceuticals Inc. shares in Q2 2023, an estimated $4.53K.
  • Simplex Trading first reported a position in Navidea Biopharmaceuticals Inc. in Q4 2014 and held it in 17 quarters.
  • Simplex Trading's Navidea Biopharmaceuticals Inc. position peaked at $73K in Q2 2020.
  • 23 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.